Ocugen Share Price

Ocugen Share Price

NASDAQ: OCGN | Micro Cap | Healthcare
$0.73
-$0.03 (-3.71%) Last updated on 19 Nov, 2026 | 01:26 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • Similar Stocks
  • FAQs

Ocugen Stock Performance

Open
$0.75
Prev. Close
$0.76
Circuit Range
N/A
Day Range
$0.73 - $0.80
Year Range
$0.69 - $2.72
Volume
97,715
Average Traded
$0.74

Ocugen Share Price Today

As of 19 November 2026, Ocugen, Inc.'s share price is $0.73. The stock opened at $0.75, compared to its previous close of $0.76. During today's trading session, Ocugen, Inc.'s share price traded between $0.73 and $0.80, with an average price of $0.76. Over the past 52 weeks, the stock has recorded a high of $2.72 and a low of $0.69. In terms of performance, Ocugen, Inc.'s share price has declined by 47.31% over the last six months and is down 41.36% on a year-on-year basis.

Ocugen Share Price Chart

Line chart of the Ocugen price trend over the selected period. The price fell overall, ranging from 0.72 to 0.80, ending at 0.73.
$0.73$0.80
L
Show Current Price
H

Ocugen Stock Fundamentals & Key Indicators

Market Cap
$218.25M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.14
Revenue (TTM)
$4.41B
Return On Equity (TTM)
269.51%
Profit Margin
-1538.55%
Debt to Equity
-4.80
Quarterly Earnings Growth YoY
N/A

Ocugen Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
RevenueN/A$1.53$1.49$1.95
Net ProfitN/A-$19.18-$24.88-$3.60
Net Profit MarginN/A-1253.59%-1669.80%-184.62%
Income ChangeN/AN/A-29.72%85.53%

Ocugen Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$2.49$6.04$4.06$4.41
Net Profit-$86.80-$63.08-$54.05-$67.85
Net Profit Margin-3485.94%-1044.37%-1331.28%-1538.55%
Income ChangeN/A27.33%14.32%-25.53%

Ocugen Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets19.1820.7621.5810.14
Current Assets24.3461.6842.9798.49
Total Assets43.5282.4464.55108.63
Non Current Liabilities32.6431.226.896.12
Current Liabilities23.0421.5917.0928.53
Total Liabilities55.6852.8123.9834.65
Shareholders' Equity-12.1729.6340.5673.98

Ocugen Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-56.96-42.14-62.05-60.08
Investing-0.31-3.393.08-16.97
Financing17.3364.8620.8859.48

About Ocugen

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Ocugen Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.71
$0.73
+3.27%
Oct 2026
$1.02
$0.70
-31.98%
Sep 2026
$1.32
$1.03
-24.73%
Aug 2026
$1.25
$1.38
+10.00%
Jul 2026
$1.54
$1.25
-18.83%
Jun 2026
$1.37
$1.54
+11.59%
May 2026
$1.73
$1.38
-20.46%
Apr 2026
$1.84
$1.74
-4.41%
Mar 2026
$1.67
$1.81
-0.27%
Feb 2026
$1.45
$1.82
+25.09%
Jan 2026
$1.36
$1.46
+8.58%
Dec 2025
$1.25
$1.34
+8.06%

Ocugen Share Price FAQs